Patents by Inventor Ju Mi Han

Ju Mi Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating fibrosis
    Patent number: 12678436
    Abstract: The pharmaceutical composition according to the present invention is used at specific therapeutic regimen and dosage, and can be usefully used for the prevention or treatment of fibrosis.
    Type: Grant
    Filed: May 2, 2022
    Date of Patent: July 14, 2026
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: Caroline Hee Lee, Min Jae Cho, Min Young Park, Ju Mi Han, Joon Seok Park
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS IN ANIMAL OF FAMILY CANIDAE, COMPRISING ENAVOGLIFLOZIN
    Publication number: 20240245641
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating diabetes mellitus in an animal of the family Canidae, including enavogliflozin as an active ingredient. The pharmaceutical composition, of the present invention, including enavogliflozin as an active ingredient exhibits an excellent blood glucose level control effect and thus can be effectively used for treating diabetes mellitus in an animal of the family Canidae.
    Type: Application
    Filed: May 20, 2022
    Publication date: July 25, 2024
    Inventors: Wan Huh, Hyun Woo Lim, Ji Soo Choi, Ju Mi Han, Joon Seok Park
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING FIBROSIS
    Publication number: 20240216363
    Abstract: The pharmaceutical composition according to the present invention is used at specific therapeutic regimen and dosage, and can be usefully used for the prevention or treatment of fibrosis.
    Type: Application
    Filed: May 2, 2022
    Publication date: July 4, 2024
    Inventors: Caroline Hee Lee, Min Jae Cho, Min Young Park, Ju Mi Han, Joon Seok Park